Trial: 201807022

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

Phase

II

Principal Investigator

Picus, Joel

Disease Site

Urinary Bladder

Learn more about this study at: clinicaltrials.gov